Hetastarch

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

1 NDC API

1 NDC API

DOSSIERs // Finished Dosage Formulations

17 Dossiers, 17 South Africa

List of Suppliers

Full Screen View

Reset Filter

Price Info

Fresenius Kabi AUT GmbH

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Sweden

Virtual Booth

Digital Content

HETASTARCH

PDF Supplier PDF

URL Supplier Web Content

Active Ingredient

Hetastarch

Dosage Form (Strength)

POWDER (25kg/25kg)

Marketing Category

BULK INGREDIENT

NDC Package Code

18124-009

Start Marketing Date

1995-01-01

End Marketing Date

2024-12-31

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 9004-62-0 / Hetastarch API manufacturers, exporters & distributors?

PharmaCompass offers a list of Hetastarch API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hetastarch manufacturer or Hetastarch supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hetastarch manufacturer or Hetastarch supplier.

PharmaCompass also assists you with knowing the Hetastarch API Price utilized in the formulation of products. Hetastarch API Price is not always fixed or binding as the Hetastarch Price is obtained through a variety of data sources. The Hetastarch Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Hetastarch

Synonyms

9004-62-0, 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol, 2-hydroxyethyl cellulose, Hydroxyethyl-cellulose, Schembl23306563, Dtxsid60873934

Cas Number

9004-62-0

About Hetastarch

Hetastarch is a synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic.

Hetastarch Manufacturers

A Hetastarch manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hetastarch, including repackagers and relabelers. The FDA regulates Hetastarch manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hetastarch API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Hetastarch Suppliers

A Hetastarch supplier is an individual or a company that provides Hetastarch active pharmaceutical ingredient (API) or Hetastarch finished formulations upon request. The Hetastarch suppliers may include Hetastarch API manufacturers, exporters, distributors and traders.

Hetastarch NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hetastarch as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Hetastarch API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Hetastarch as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Hetastarch and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hetastarch NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Hetastarch suppliers with NDC on PharmaCompass.

Hetastarch Manufacturers | Traders | Suppliers

We have 1 companies offering Hetastarch

Get in contact with the supplier of your choice:

Fresenius Kabi AB Brunna

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.